Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bausch Health Companies (TSE:BHC)
TSX:BHC
RESEARCH TOOLSreports
Holding TSE:BHC?
Track your performance easily
BHC Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$5.45 - C$15.43
Previous CloseC$7.91
Volume213.94K
Average Volume (3M)410.64K
Market Cap
C$2.90B
Enterprise ValueC$32.88B
Total Cash (Recent Filing)$595.00M
Total Debt (Recent Filing)$21.66B
Price to Earnings (P/E)―
Beta1.02
Next Earnings
Oct 31, 2024EPS Estimate
C$1.44Last Dividend Ex-Date
Nov 10, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)-1.73
Shares Outstanding367,102,862
10 Day Avg. Volume237,642
30 Day Avg. Volume410,645
Standard Deviation0.16
R-Squared0.06
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.12
Price to Sales (P/S)0.23
Price to Cash Flow (P/CF)1.40
P/FCF Ratio1.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.58
Enterprise Value/Gross Profit5.31
Enterprise Value/Ebitda19.15
Forecast
1Y Price Target
C$11.39Price Target Upside43.98% Upside
Rating ConsensusHold
Number of Analyst Covering7
Bausch Health Companies News
PremiumCompany Announcements
Bausch Health Reports Strong Q2 Growth, Raises Guidance
Bulls Say, Bears Say
Bulls Say
Guidance2024 guidance for consolidated BHC was raised slightly.
Product SalesXifaxan sales of $485MM in the quarter exceeded projections by $30MM, growing 10% year-over-year.
Sales PerformanceBausch & Lomb sales reached $1,216MM, surpassing estimates by $36MM.
Bears Say
Bankruptcy RiskBHC Shares React To Unconfirmed Potential Report Of Bankruptcy.
Debt MaturitiesUpcoming debt maturities in 2025-2026 are a concern with total debt of $22B against cash of $755M and leverage at 6.7x.
SolvencyDowngrading Bausch to Underweight from Neutral due to concerns over solvency.
---
BHC FAQ
What was Bausch Health Companies’s price range in the past 12 months?
Bausch Health Companies lowest stock price was C$5.45 and its highest was C$15.43 in the past 12 months.
What is Bausch Health Companies’s market cap?
Currently, no data Available
When is Bausch Health Companies’s upcoming earnings report date?
Bausch Health Companies’s upcoming earnings report date is Oct 31, 2024 which is in 68 days.
How were Bausch Health Companies’s earnings last quarter?
Bausch Health Companies released its earnings results on Jul 31, 2024. The company reported C$1.475 earnings per share for the quarter, beating the consensus estimate of C$1.204 by C$0.271.
Is Bausch Health Companies overvalued?
According to Wall Street analysts Bausch Health Companies’s price is currently Undervalued.
Does Bausch Health Companies pay dividends?
Bausch Health Companies pays a Quarterly dividend of C$1.36 which represents an annual dividend yield of N/A. See more information on Bausch Health Companies dividends here
What is Bausch Health Companies’s EPS estimate?
Bausch Health Companies’s EPS estimate is C$1.44.
How many shares outstanding does Bausch Health Companies have?
Bausch Health Companies has 367,102,870 shares outstanding.
What happened to Bausch Health Companies’s price movement after its last earnings report?
Bausch Health Companies reported an EPS of C$1.475 in its last earnings report, beating expectations of C$1.204. Following the earnings report the stock price went up 0.726%.
Which hedge fund is a major shareholder of Bausch Health Companies?
Among the largest hedge funds holding Bausch Health Companies’s share is Carl Icahn C. It holds Bausch Health Companies’s shares valued at 242M.
---
Bausch Health Companies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
C$11.39 (43.98% Upside)
C$11.39 (43.98% Upside)
Blogger Sentiment
Bullish
TSE:BHC Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 4.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.06%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.89%
Trailing 12-Months
Company Description
Bausch Health Companies
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets.
---
BHC Company Deck
---
BHC Earnings Call
Q2 2024
0:00 / 0:00
---
BHC Revenue Breakdown
44.64% Pharmaceuticals
22.80% Devices
20.52% OTC
10.96% Branded and Other Generics
1.07% Other
---
BHC Stock 12 Month Forecast
Average Price Target
C$11.39
▲(43.98% Upside)
Technical Analysis
Bausch Health Companies
―
Teva Pharmaceutical
―
Perrigo Company
―
Innoviva
―
Pfizer
―
Best Analysts Covering BHC
1 Year
1 Year Success Rate
12/28 ratings generated profit
1 Year Average Return
-6.76%
downgraded a sell rating 23 days ago
Copying David Amsellem's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -6.76% per trade.
---